These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 1242348
1. [The role of clinical psychiatry in the development of new drugs]. Benkert O, Hippius H. Arzneimittelforschung; 1975 Jul; 25(7a):1195-206. PubMed ID: 1242348 [Abstract] [Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H, Namba K. Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [Abstract] [Full Text] [Related]
3. Drug safety in psychiatry--an objective for drug monitoring in phase IV. Schmidt LG, Müller-Oerlinghausen B. Pharmacopsychiatry; 1984 Sep; 17(5):152-6. PubMed ID: 6494244 [Abstract] [Full Text] [Related]
5. Academic psychiatry and the pharmaceutical industry. Ban TA. Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):429-41. PubMed ID: 16442686 [Abstract] [Full Text] [Related]
6. New drug developments in the Latin Americas (Argentina, Costa Rica, Mexico and Panama). Ban TA, Galvan L, Udabe RU, Vergara L, Zoch C. Dis Nerv Syst; 1974 Jul; 35(7 Pt. 2):33-6. PubMed ID: 17894101 [Abstract] [Full Text] [Related]
7. Pharmacogenomics, informatics, and individual drug therapy in psychiatry: past, present and future. Preskorn SH. J Psychopharmacol; 2006 Jul; 20(4 Suppl):85-94. PubMed ID: 16785276 [Abstract] [Full Text] [Related]
8. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit]. Armand-Branger S, Poisson N, Gaudoneix-Taïeb M, Ramos O. Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374 [Abstract] [Full Text] [Related]
9. Pharmacotherapy and psychotherapy: paradoxes problems and progress. Formulated by the Committee on Research. Rep Group Adv Psychiatry; 1975 Mar; 9(93):263-434. PubMed ID: 1092600 [No Abstract] [Full Text] [Related]
10. [Attitude of medical students to treatment with psychotropic drugs. 2: Change in attitude in the course of medical education]. Hillert A, Sandmann J, Angermeyer MC, Däumer R. Psychiatr Prax; 1994 Mar; 21(2):64-9. PubMed ID: 8197264 [Abstract] [Full Text] [Related]
11. [The new biological revolution in psychiatry: a Latin American point of view (2)]. Alarcón RD. Acta Psiquiatr Psicol Am Lat; 1985 Sep; 31(3):173-90. PubMed ID: 2870607 [Abstract] [Full Text] [Related]
12. Towards a clinical methodology for neuropsychopharmacological research. Ban TA. Neuropsychopharmacol Hung; 2007 Jun; 9(2):81-90. PubMed ID: 17970531 [Abstract] [Full Text] [Related]
13. International aspects of problems associated with the use of psychoactive drugs. Chruściel TL. Bull Narc; 1976 Jun; 28(2):35-48. PubMed ID: 1048933 [Abstract] [Full Text] [Related]
14. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders]. Baghdadli A, Gonnier V, Aussilloux C. Encephale; 2002 Jun; 28(3 Pt 1):248-54. PubMed ID: 12091786 [Abstract] [Full Text] [Related]
15. Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations. Sheppard C, Beyel V, Fracchia J, Merlis S. Dis Nerv Syst; 1974 Apr; 35(4):183-9. PubMed ID: 17894114 [Abstract] [Full Text] [Related]
17. A psychopharmacology education program for psychiatry residents--the role of a clinical pharmacist. Dorevitch A. Isr J Psychiatry Relat Sci; 1994 Apr; 31(4):287-91. PubMed ID: 7875953 [Abstract] [Full Text] [Related]
18. New directions in clinical psychopharmacology. Cardoni AA. Conn Med; 1997 Sep; 61(9):587-95. PubMed ID: 9334514 [Abstract] [Full Text] [Related]